Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer

Pancreatic cancer is often associated with an intense production of interstitial collagens, known as the desmoplastic reaction. To understand more about desmoplasia in pancreatic cancer, the expression of mRNA for type I and III collagens and potent desmoplastic inducing growth factors transforming growth factor-β (TGF-β), connective tissue growth factor (CTGF), acidic and basic fibroblast growth factor (FGF), platelet-derived growth factor (PDGF) A and C and epidermal growth factor (EGF) was analysed by quantitative RT–PCR. Expression of both collagens in 23 frozen primary pancreatic cancer nodules was significantly higher than that in 15 non-neoplastic pancreatic tissues. The expressions of mRNAs for TGF-β, acidic FGF, basic FGF and PDGF C were likewise higher in surgical cancer nodules, while that of CTGF, PDGF A and EGF were not. Among these growth factors, the expression of TGF-β mRNA showed the most significant correlation with that of collagens (P<0.0001). By immunohistochemistry, TGF-β showed faint cytoplasmic staining in cancer cells. In contrast, isolated cells, mainly located on the invasive front surrounding cancerous nests, were prominently and strongly stained. These TGF-β-positive cells contained a segmented nucleus, were negative for anti-macrophage (CD68) and positive for anti-granulocyte antibodies, indicating their granulocytic nature. In conclusion, TGF-β seemed to play a major role among the various growth factors in characteristic overproduction of collagens in pancreatic cancer. Moreover, the predominant cells that express TGF-β were likely to be infiltrated granulocytes (mostly are neutrophils) and not pancreatic cancer cells.

[1]  H. Friess,et al.  Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. , 1993, Cancer research.

[2]  P. Colville-Nash,et al.  Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[3]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[4]  K. Takehara,et al.  Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. , 1997, Biochemical and biophysical research communications.

[5]  M. Imamura,et al.  Quantitative Analysis of Collagen and Collagen Subtypes I, III, and V in Human Pancreatic Cancer, Tumor‐Associated Chronic Pancreatitis, and Alcoholic Chronic Pancreatitis , 1995, Pancreas.

[6]  J. Rosenbloom,et al.  Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. , 1987, The Biochemical journal.

[7]  H. Friess,et al.  Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer , 1995, International journal of cancer.

[8]  H. Friess,et al.  Adjuvant therapy in pancreatic cancer: historical and current perspectives. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  J. Malin,et al.  Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis. , 1996, Journal of the neurological sciences.

[10]  D. Wong,et al.  Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. , 1991, Blood.

[11]  N. Khalil TGF-β: from latent to active , 1999 .

[12]  M. Sporn,et al.  Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Sekizawa,et al.  Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor‐bβ , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  W. Schürch,et al.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[15]  M. Krupsky,et al.  Regulation of type I collagen production by insulin and transforming growth factor-beta in human lung fibroblasts. , 1996, Connective tissue research.

[16]  E. Castaños-Vélez,et al.  Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. , 2001, Hepato-gastroenterology.

[17]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[18]  J. Malin,et al.  Expression of tumor necrosis factor-α and transforming growth factor-β1 in cerebrospinal fluid cells in meningitis , 1996, Journal of the Neurological Sciences.

[19]  E. Tahara Growth factors and oncogenes in human gastrointestinal carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.

[20]  A. Fine,et al.  The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. , 1987, The Journal of biological chemistry.

[21]  H. Kern,et al.  Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases , 1985, Histopathology.

[22]  H. Friess,et al.  Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .

[23]  M. Nicholson,et al.  Intragraft expression of transforming growth factor β1 gene in isolated glomeruli from human renal transplants , 1999, The British journal of surgery.

[24]  H. Hameister,et al.  Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.

[25]  M. Sporn,et al.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation , 1989, The Journal of experimental medicine.

[26]  Gary R. Grotendorst,et al.  Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils , 1989, Journal of cellular physiology.

[27]  D. Rifkin,et al.  TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .

[28]  S. Wahl,et al.  Transforming growth factor β: a matter of life and death , 1994 .

[29]  D. Gospodarowicz Growth factors and their action in vivo and in vitro , 1983, The Journal of pathology.

[30]  H. Friess,et al.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. , 1992, The Journal of clinical investigation.

[31]  R. Takimoto,et al.  Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. , 1994, British Journal of Cancer.

[32]  T. Stukel,et al.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. , 1992, Cancer research.

[33]  J. Barrett,et al.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. , 1989, The American journal of pathology.

[34]  H. Yokozaki,et al.  Expression of TGF‐β and procollagen type I and type III in human gastric carcinomas , 1989 .

[35]  A. Abioye,et al.  Pancreatic carcinoma. , 2020, Journal of the National Medical Association.

[36]  L. Gold The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.

[37]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Ståhle-Bäckdahl Increased Presence of Eosinophilic Granulocytes Expressing Transforming Growth Factor-ß1 in Collagenous Colitis , 2000, Scandinavian journal of gastroenterology.

[39]  S. Wahl,et al.  Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.

[40]  R. Hruban,et al.  Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.

[41]  Y. Luqmani,et al.  Transcripts for transforming growth factors in human breast cancer: clinical correlates. , 1990, British Journal of Cancer.

[42]  T. Yeatman,et al.  Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival. , 1998, American journal of clinical pathology.

[43]  H. Friess,et al.  Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer , 1995, International journal of cancer.

[44]  K. Miyazono,et al.  Transforming growth factor-beta: latent forms, binding proteins and receptors. , 1993, Growth factors.

[45]  Y. Niitsu,et al.  Immunohistochemical identification of type I procollagen in tumour cells of scirrhous adenocarcinoma of the stomach. , 1988, British Journal of Cancer.

[46]  R. Walker,et al.  Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. , 1992, European Journal of Cancer.

[47]  N. Khalil TGF-beta: from latent to active. , 1999, Microbes and infection.

[48]  C. Powers,et al.  Fibroblast growth factors, their receptors and signaling. , 2000, Endocrine-related cancer.

[49]  D. Rifkin,et al.  TGF-beta latency: biological significance and mechanisms of activation. , 1997, Stem cells.

[50]  K. Takehara,et al.  Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta--simultaneous application with basic fibroblast growth factor causes persistent fibrosis. , 1997, Biochemical and biophysical research communications.

[51]  Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. , 1994, British journal of cancer.

[52]  H. Moses,et al.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.

[53]  P. Brun,et al.  Growth factors and collagen distribution in vernal keratoconjunctivitis. , 2000, Investigative ophthalmology & visual science.